Generic Injectable Market

The generic injectable market was valued at USD 135.4 billion in 2025 and is forecast to register an 11.5% CAGR between 2025 and 2035. In 2025, monoclonal antibodies hold ~38.7% of product demand, small molecules represent 62.8% of molecule type sales and tier 1 companies account for ~58.0% within the players segment.